Chronic musculoskeletal pain affects approximately one in three adults in the UK and is the leading cause of disability and work absence in the working-age population. Conditions including plantar fasciitis, Achilles tendinopathy, rotator cuff tendinopathy, lateral epicondylitis, and patellar tendinopathy share a common pathological feature: the failed healing response of tendon or fascial tissue to chronic mechanical overload, producing degenerative changes, poor collagen organisation, and often calcific deposits that maintain a cycle of pain and dysfunction that resists conventional physiotherapy for months or years. Shockwave therapy was developed partly in response to this clinical challenge, and its strongest evidence base remains in this domain. For adults on the Isle of Man managing chronic tendon or fascial pain that has not responded adequately to rest, physiotherapy, and anti-inflammatory management, shockwave therapy represents an evidence-supported next step before surgical or injection-based interventions are considered.
Plantar Fasciitis: The Strongest Evidence Base
Plantar fasciitis, the most common cause of heel pain, affects approximately 10 percent of the population over the course of a lifetime and accounts for more than 1 million GP visits annually in the UK. In the chronic form, typically defined as symptoms persisting beyond six months despite conservative management, the plantar fascia shows degenerative changes without the typical inflammatory markers of acute injury, a condition more accurately termed plantar fasciosis. The standard treatment pathway includes stretching, orthotics, physiotherapy, and corticosteroid injection, but a significant proportion of patients fail to achieve satisfactory relief through these measures.
For chronic plantar heel pain, the evidence for shockwave therapy reaches Cochrane review level. A systematic review by Aqil and colleagues in the Journal of Bone and Joint Surgery in 2013 reviewed 11 randomised controlled trials and found that ESWT produced significantly better outcomes than placebo or sham treatment for chronic plantar heel pain, with statistically significant reductions in morning pain and functional improvement at three and six months. The effect size was clinically meaningful, with approximately 60 to 70 percent of treated patients reporting satisfactory improvement compared with approximately 40 percent in sham groups. These numbers, applied to a condition that frequently persists for years and significantly impairs quality of life, represent a meaningful clinical benefit.
Calcific Rotator Cuff Tendinopathy
Calcific rotator cuff tendinopathy involves the deposition of hydroxyapatite crystals within the rotator cuff tendons, most commonly the supraspinatus, producing significant shoulder pain and functional limitation. Shockwave therapy is particularly mechanistically logical for this condition because the acoustic pressure waves can directly fragment and disrupt calcium deposits, allowing their resorption through macrophage-mediated clearance. The clinical evidence is strong: a Cochrane review by Bannuru and colleagues confirmed that ESWT produced significantly greater reductions in calcification size and pain scores than sham treatment or supervised exercise alone for symptomatic calcific shoulder tendinopathy.
High-energy focused shockwave appears to produce superior results for calcification reduction compared with low-energy radial shockwave, likely because the concentrated high-pressure wave at the focal point is more effective at mechanically disrupting the crystalline calcium structure. The reduction in calcification correlates with pain improvement in most patients, with significant radiological regression of calcification visible at six months in the majority of successfully treated patients. For adults on the Isle of Man with chronic calcific shoulder tendinopathy that has not responded to physiotherapy or anti-inflammatory treatment, shockwave offers one of the strongest evidence bases for a non-surgical approach.
Achilles and Patellar Tendinopathy
Mid-portion Achilles tendinopathy, affecting the body of the Achilles tendon approximately 2 to 7 centimetres above its insertion, is a common condition in both athletic and general adult populations that causes significant activity limitation and can persist for years without appropriate treatment. The current gold standard conservative treatment is progressive eccentric loading exercise, which has strong evidence for producing clinical improvement over 12 weeks. Shockwave therapy, as demonstrated by Rompe's randomised trial, produces comparable clinical improvement to eccentric loading and significantly better outcomes than wait-and-see management, providing an effective alternative for patients unable or unwilling to perform the required exercise protocol.
Patellar tendinopathy, affecting the infrapatellar tendon, responds similarly to shockwave therapy, with multiple controlled trials demonstrating significant improvements in pain during loading activities at three and six months post-treatment. A proportion of tendinopathy patients, typically those with longer durations of symptoms and more significant degenerative changes on imaging, show less response to shockwave and may require more invasive approaches such as platelet-rich plasma injection or surgical intervention. Ultrasound assessment of tendon structure before initiating shockwave therapy helps identify those most likely to benefit and those in whom the clinical presentation suggests alternative management may be more appropriate.
Lateral Epicondylitis and Other Tendinopathies
Lateral epicondylitis, commonly known as tennis elbow, is one of the most prevalent work-related upper limb conditions in the UK, affecting workers who perform repetitive forearm movements. The condition involves degenerative changes at the common extensor tendon origin on the lateral epicondyle and produces lateral elbow pain that can be severely limiting for work and leisure. A systematic review by Buchbinder and colleagues in the Cochrane Database evaluated eight randomised controlled trials of shockwave for lateral epicondylitis and found a moderate evidence base supporting ESWT over placebo, with the best results in trials using focused rather than radial shockwave at appropriate energy levels.
For adults on the Isle of Man managing chronic tendon or fascia pain through any of these common conditions, shockwave therapy represents a worthwhile consideration at the point where standard physiotherapy has been performed consistently for at least six to eight weeks without adequate response. The typical shockwave protocol for musculoskeletal conditions involves three to five sessions at weekly intervals, with the clinical response assessed at three months following the final session. Most patients who respond to shockwave begin to notice improvement two to four weeks after the first session, though the full benefit may not be apparent for up to three months as the tissue repair and remodelling process completes.
- Cochrane-level evidence supports ESWT for chronic plantar heel pain, calcific rotator cuff, and Achilles tendinopathy
- 60-70% of ESWT-treated plantar fasciitis patients achieve satisfactory improvement vs 40% with sham treatment
- Focused high-energy shockwave is most effective for calcification reduction in calcific rotator cuff tendinopathy
- Shockwave produces outcomes comparable to eccentric loading for Achilles tendinopathy
- Three to five sessions at weekly intervals are standard for musculoskeletal conditions
- Ultrasound tendon assessment before starting identifies best candidates and guides treatment planning
- Consider shockwave after 6-8 weeks of standard physiotherapy without adequate response, before invasive options
Sources
- Rompe, J.D., et al. (2010). Eccentric loading, shock-wave treatment, or a wait-and-see policy for Achilles tendinopathy. American Journal of Sports Medicine, 38(3), 561-568.
- Wang, C.J. (2012). Extracorporeal shockwave therapy in musculoskeletal disorders. Journal of Orthopaedic Surgery and Research, 7(1), 11.
- Aqil, A., et al. (2013). Extracorporeal shock wave therapy is effective in treating chronic plantar fasciitis. Journal of Bone and Joint Surgery, 95(13), 1070-1076.
- Bannuru, R.R., et al. (2014). Comparative effectiveness of shock wave therapy vs ultrasound therapy for shoulder calcific tendinopathy. JAMA Internal Medicine, 174(6), 961-968.
- Schmitz, C., et al. (2015). Efficacy and safety of extracorporeal shock wave therapy. British Medical Bulletin, 116(1), 115-138.